Systemic Inflammation Markers and Hepatic Encephalopathy After TIPS
Author Information
Author(s): Tiede Anja, Stockhoff Lena, Ehrenbauer Alena F., Rieland Hannah, Cornberg Markus, Meyer Bernhard C., Gabriel Maria M., Wedemeyer Heiner, Hinrichs Jan B., Weissenborn Karin, Falk Christine S., Maasoumy Benjamin
Primary Institution: Hannover Medical School, Hannover, Germany
Hypothesis
Are systemic inflammation markers linked to the development of minimal and overt hepatic encephalopathy after TIPS insertion?
Conclusion
The study found no significant link between systemic inflammation markers and the development of overt hepatic encephalopathy after TIPS insertion.
Supporting Evidence
- 19 (30.6%) patients developed overt hepatic encephalopathy during follow-up.
- 67.9% presented with minimal hepatic encephalopathy before TIPS.
- All systemic inflammation markers showed a significant decline during follow-up.
Takeaway
Doctors wanted to see if certain inflammation markers could help predict brain problems in patients after a specific liver procedure, but they didn't find a clear connection.
Methodology
The study included 62 patients who underwent TIPS insertion and monitored them for the development of overt hepatic encephalopathy over two years, measuring inflammation markers and conducting psychometric tests.
Potential Biases
Potential bias due to exclusion of patients with active infections and hemodialysis.
Limitations
The sample size was relatively small, and patients with active infections or hemodialysis were excluded, limiting generalizability.
Participant Demographics
Predominantly male (64.5%) with a median age of 58 years; most had liver cirrhosis due to alcohol-related disease.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website